HUGO_167
|
BBC |
Bronze Age |
Germany |
M |
-2270 |
-2039 |
U5b2b3a |
reconstructed
|
195.80
|
|
FASTA
Metadata
|
|
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
12634G (MT-ND5): Thyroid Cancer Cell Line (Reported)
-
13637G (MT-ND5): Possible LHON factor (Reported)
-
150T (MT-CR): Longevity / Cervical Carcinoma / HPV infection risk (Conflicting reports)
-
2755G (MT-RNR2): Possibly LVNC-associated (Reported)
-
16270T (MT-CR): Melanoma patients (Reported)
|
HUGO_168
|
BBC |
Bronze Age |
Germany |
F |
-2289 |
-2141 |
H1 |
reconstructed
|
620.10
|
|
FASTA
Metadata
|
|
-
3010A (MT-RNR2): Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor (Reported)
|
POST_3
|
EBAGe |
Bronze Age |
Germany |
U |
-2019 |
-1890 |
None |
<NA>
|
3.50
|
|
Metadata
|
|
|
POST_16
|
EBAGe |
Bronze Age |
Germany |
F |
-2029 |
-1911 |
T2f8a |
reconstructed
|
303.40
|
|
FASTA
Metadata
|
|
-
11251G (MT-ND4): Reduced risk of PD (Reported)
-
146C (MT-CR): Absence of Endometriosis (Reported)
-
15928A (MT-TT): Multiple Sclerosis / idiopathic repeat miscarriage / AD protection (Reported)
-
16189C (MT-CR): Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients (Reported)
-
3243G (MT-TL1): MELAS / Leigh Syndrome / DMDF / MIDD / SNHL / CPEO / MM / FSGS / ASD / Cardiac+multi-organ dysfunction (Cfrm)
-
4216C (MT-ND1): LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage (Conflicting reports)
-
4917G (MT-ND2): LHON / Insulin Resistance / AMD / NRTI-PN (Reported)
|
HUGO_169sk1
|
BBC |
Bronze Age |
Germany |
M |
-2562 |
-2345 |
U5a2b3 |
reconstructed
|
949.10
|
|
FASTA
Metadata
|
|
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
16192T (MT-CR): Melanoma patients (Reported)
-
16270T (MT-CR): Melanoma patients (Reported)
|
POST_21
|
EBAGe |
Bronze Age |
Germany |
M |
-2025 |
-1903 |
None |
<NA>
|
3.60
|
|
Metadata
|
|
|
POST_32
|
EBAGe |
Bronze Age |
Germany |
F |
-2032 |
-1916 |
T2 |
reconstructed
|
1048.10
|
|
FASTA
Metadata
|
|
-
11251G (MT-ND4): Reduced risk of PD (Reported)
-
15928A (MT-TT): Multiple Sclerosis / idiopathic repeat miscarriage / AD protection (Reported)
-
4216C (MT-ND1): LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage (Conflicting reports)
-
4917G (MT-ND2): LHON / Insulin Resistance / AMD / NRTI-PN (Reported)
|
HUGO_169sk2
|
BBC |
Bronze Age |
Germany |
F |
-2461 |
-2211 |
U5a2b3 |
reconstructed
|
35.10
|
|
FASTA
Metadata
|
|
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
16192T (MT-CR): Melanoma patients (Reported)
-
16270T (MT-CR): Melanoma patients (Reported)
|
POST_38
|
EBAGe |
Bronze Age |
Germany |
M |
-2197 |
-2034 |
H1e |
reconstructed
|
38.30
|
|
FASTA
Metadata
|
|
-
16189C (MT-CR): Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients (Reported)
-
3010A (MT-RNR2): Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor (Reported)
-
5460A (MT-ND2): AD / PD / LHON (Conflicting reports)
|
HUGO_170
|
BBC |
Bronze Age |
Germany |
M |
-2288 |
-2066 |
U4d3 |
reconstructed
|
475.40
|
|
FASTA
Metadata
|
|
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
14577C (MT-ND6): MIDM (Reported)
-
15693C (MT-CYB): Possibly LVNC cardiomyopathy-associated (Reported)
-
16189C (MT-CR): Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients (Reported)
-
195C (MT-CR): BD-associated / melanoma pts (Reported)
-
499A (MT-CR): Endometriosis (Reported)
|
HUGO_171
|
BBC |
Bronze Age |
Germany |
F |
-2387 |
-2146 |
U5a1a1 |
reconstructed
|
424.90
|
|
FASTA
Metadata
|
|
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
15924G (MT-TT): LIMM (Reported)
-
16270T (MT-CR): Melanoma patients (Reported)
|
HUGO_180sk
|
BBC |
Bronze Age |
Germany |
M |
-2461 |
-2210 |
U5b2b4 |
reconstructed
|
1693.00
|
|
FASTA
Metadata
|
|
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
12634G (MT-ND5): Thyroid Cancer Cell Line (Reported)
-
13637G (MT-ND5): Possible LHON factor (Reported)
-
150T (MT-CR): Longevity / Cervical Carcinoma / HPV infection risk (Conflicting reports)
-
16189C (MT-CR): Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients (Reported)
-
16270T (MT-CR): Melanoma patients (Reported)
|
HUGO_180sk2
|
BBC |
Bronze Age |
Germany |
M |
-2463 |
-2235 |
U5b2b4 |
reconstructed
|
879.30
|
|
FASTA
Metadata
|
|
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
12634G (MT-ND5): Thyroid Cancer Cell Line (Reported)
-
13637G (MT-ND5): Possible LHON factor (Reported)
-
150T (MT-CR): Longevity / Cervical Carcinoma / HPV infection risk (Conflicting reports)
-
16189C (MT-CR): Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients (Reported)
-
16270T (MT-CR): Melanoma patients (Reported)
|
HUGO_190
|
BBC |
Bronze Age |
Germany |
F |
-2268 |
-2046 |
J1c3g |
reconstructed
|
130.90
|
|
FASTA
Metadata
|
|
-
11251G (MT-ND4): Reduced risk of PD (Reported)
-
10398G (MT-ND3): PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy (Reported / lineage L & M marker / also hg IJK)
-
13708A (MT-ND5): LHON / Increased MS risk / higher freq in PD-ADS (Conflicting reports)
-
185A (MT-CR): Low VO2max response (Reported)
-
295T (MT-CR): Low VO2max response (Reported)
-
3010A (MT-RNR2): Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor (Reported)
-
228A (MT-CR): Low VO2max response (Reported)
-
4216C (MT-ND1): LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage (Conflicting reports)
-
462T (MT-CR): Low VO2max response (Reported)
-
489C (MT-CR): Low VO2max response (Reported)
|
POST_1
|
EBAGe |
Bronze Age |
Germany |
F |
-2024 |
-1882 |
H2a1a |
reconstructed
|
280.30
|
|
FASTA
Metadata
|
|
|
POST_85
|
EBAGe |
Bronze Age |
Germany |
U |
-2120 |
-1921 |
X2b+226 |
reconstructed
|
298.90
|
|
FASTA
Metadata
|
|
-
12705T (MT-CO1): Possible protective factor for normal tension glaucoma (Reported)
-
13708A (MT-ND5): LHON / Increased MS risk / higher freq in PD-ADS (Conflicting reports)
-
15927A (MT-TT): LHON / Multiple Sclerosis / DEAF1555 increased penetrance / CHD (Reported)
-
16189C (MT-CR): Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients (Reported)
-
195C (MT-CR): BD-associated / melanoma pts (Reported)
-
8393T (MT-ATP8): Reversible brain pseudoatrophy (Reported)
|
POST_2
|
EBAGe |
Bronze Age |
Germany |
U |
-2126 |
-1948 |
None |
<NA>
|
1.30
|
|
Metadata
|
|
|
POST_6
|
EBAGe |
Bronze Age |
Germany |
M |
-2009 |
-1883 |
U5a1a1+16362 |
reconstructed
|
233.80
|
|
FASTA
Metadata
|
|
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
15924G (MT-TT): LIMM (Reported)
-
16270T (MT-CR): Melanoma patients (Reported)
|
POST_12
|
EBAGe |
Bronze Age |
Germany |
U |
-2190 |
-2028 |
J1c3g |
reconstructed
|
14.60
|
|
FASTA
Metadata
|
|
-
11251G (MT-ND4): Reduced risk of PD (Reported)
-
10398G (MT-ND3): PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy (Reported / lineage L & M marker / also hg IJK)
-
13708A (MT-ND5): LHON / Increased MS risk / higher freq in PD-ADS (Conflicting reports)
-
185A (MT-CR): Low VO2max response (Reported)
-
295T (MT-CR): Low VO2max response (Reported)
-
3010A (MT-RNR2): Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor (Reported)
-
4216C (MT-ND1): LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage (Conflicting reports)
-
4435G (MT-TM): LHON modulator / hypertension / autism spectrum / intellectual disability (Reported)
-
462T (MT-CR): Low VO2max response (Reported)
-
489C (MT-CR): Low VO2max response (Reported)
|
POST_137
|
EBAGe |
Bronze Age |
Germany |
M |
-2029 |
-1912 |
T2c1d+152 |
reconstructed
|
46.90
|
|
FASTA
Metadata
|
|
-
11251G (MT-ND4): Reduced risk of PD (Reported)
-
146C (MT-CR): Absence of Endometriosis (Reported)
-
15928A (MT-TT): Multiple Sclerosis / idiopathic repeat miscarriage / AD protection (Reported)
-
4216C (MT-ND1): LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage (Conflicting reports)
-
4917G (MT-ND2): LHON / Insulin Resistance / AMD / NRTI-PN (Reported)
-
6261A (MT-CO1): Prostate Cancer / LHON (Reported)
|
POST_24
|
EBAGe |
Bronze Age |
Germany |
M |
-2137 |
-1980 |
H1b1 |
reconstructed
|
1314.80
|
|
FASTA
Metadata
|
|
-
16189C (MT-CR): Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients (Reported)
-
3010A (MT-RNR2): Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor (Reported)
-
3796G (MT-ND1): Adult-Onset Dystonia (Reported)
|
POST_28
|
EBAGe |
Bronze Age |
Germany |
M |
-2027 |
-1906 |
K2a5 |
reconstructed
|
54.90
|
|
FASTA
Metadata
|
|
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
146C (MT-CR): Absence of Endometriosis (Reported)
-
9055A (MT-ATP6): PD protective factor (Reported)
|
UNTA58-62_67
|
BBC |
Bronze Age |
Germany |
M |
-2455 |
-2204 |
K1a |
reconstructed
|
1521.50
|
|
FASTA
Metadata
|
|
|
UNTA58-62_148
|
EBAGe |
Bronze Age |
Germany |
U |
-2470 |
-1776 |
None |
<NA>
|
<NA>
|
|
Metadata
|
|
|
POST_35
|
EBAGe |
Bronze Age |
Germany |
F |
-2033 |
-1918 |
H41a |
reconstructed
|
868.70
|
|
FASTA
Metadata
|
|
-
5460A (MT-ND2): AD / PD / LHON (Conflicting reports)
|
POST_44
|
EBAGe |
Bronze Age |
Germany |
M |
-2139 |
-1979 |
K1a3a |
reconstructed
|
684.20
|
|
FASTA
Metadata
|
|
-
10398G (MT-ND3): PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy (Reported / lineage L & M marker / also hg IJK)
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
16093C (MT-CR): Cyclic Vomiting Syndrome (Reported)
-
9055A (MT-ATP6): PD protective factor (Reported)
|
POST_47
|
EBAGe |
Bronze Age |
Germany |
M |
-2134 |
-1956 |
K2a5 |
reconstructed
|
26.80
|
|
FASTA
Metadata
|
|
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
146C (MT-CR): Absence of Endometriosis (Reported)
-
9055A (MT-ATP6): PD protective factor (Reported)
|
UNTA85_113
|
BBC |
Bronze Age |
Germany |
M |
-2456 |
-2155 |
U5b2a3 |
reconstructed
|
33.70
|
|
FASTA
Metadata
|
|
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
13637G (MT-ND5): Possible LHON factor (Reported)
-
150T (MT-CR): Longevity / Cervical Carcinoma / HPV infection risk (Conflicting reports)
-
16189C (MT-CR): Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients (Reported)
-
16192T (MT-CR): Melanoma patients (Reported)
-
16270T (MT-CR): Melanoma patients (Reported)
|
UNTA85_1334
|
BBC |
Bronze Age |
Germany |
M |
-2453 |
-2152 |
H15a1 |
reconstructed
|
58.40
|
|
FASTA
Metadata
|
|
-
6253C (MT-CO1): Prostate Cancer / enriched in POAG cohort (Reported)
|
UNTA85_1336
|
BBC |
Bronze Age |
Germany |
F |
-2465 |
-2300 |
H2a1 |
reconstructed
|
54.30
|
|
FASTA
Metadata
|
|
|
POST_50
|
EBAGe |
Bronze Age |
Germany |
M |
-2196 |
-2029 |
T1a1 |
reconstructed
|
328.30
|
|
FASTA
Metadata
|
|
-
11251G (MT-ND4): Reduced risk of PD (Reported)
-
15928A (MT-TT): Multiple Sclerosis / idiopathic repeat miscarriage / AD protection (Reported)
-
16189C (MT-CR): Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients (Reported)
-
195C (MT-CR): BD-associated / melanoma pts (Reported)
-
4216C (MT-ND1): LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage (Conflicting reports)
-
4917G (MT-ND2): LHON / Insulin Resistance / AMD / NRTI-PN (Reported)
|
UNTA85_1412
|
EBAGe |
Bronze Age |
Germany |
M |
-2025 |
-1895 |
H |
<NA>
|
134.50
|
|
Metadata
|
|
|
OBKR_9B
|
EBAGe |
Bronze Age |
Germany |
F |
-2032 |
-1903 |
U5a1i1 |
reconstructed
|
160.00
|
|
FASTA
Metadata
|
|
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
16192T (MT-CR): Melanoma patients (Reported)
-
16270T (MT-CR): Melanoma patients (Reported)
|
OBKR_47
|
EBAGe |
Bronze Age |
Germany |
M |
-2136 |
-1977 |
J2b1a |
reconstructed
|
511.40
|
|
FASTA
Metadata
|
|
-
11251G (MT-ND4): Reduced risk of PD (Reported)
-
10398G (MT-ND3): PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy (Reported / lineage L & M marker / also hg IJK)
-
12397G (MT-ND5): PD / early onset (Reported)
-
13708A (MT-ND5): LHON / Increased MS risk / higher freq in PD-ADS (Conflicting reports)
-
150T (MT-CR): Longevity / Cervical Carcinoma / HPV infection risk (Conflicting reports)
-
15257A (MT-CYB): LHON (Conflicting reports)
-
15812A (MT-CYB): LHON (Reported / Secondary)
-
295T (MT-CR): Low VO2max response (Reported)
-
4216C (MT-ND1): LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage (Conflicting reports)
-
489C (MT-CR): Low VO2max response (Reported)
|
OBKR_50
|
EBAGe |
Bronze Age |
Germany |
F |
-2112 |
-1912 |
HV0 |
reconstructed
|
83.80
|
|
FASTA
Metadata
|
|
|
POST_84
|
EBAGe |
Bronze Age |
Germany |
F |
-2126 |
-1928 |
X2b+226 |
reconstructed
|
189.50
|
|
FASTA
Metadata
|
|
-
12705T (MT-CO1): Possible protective factor for normal tension glaucoma (Reported)
-
13708A (MT-ND5): LHON / Increased MS risk / higher freq in PD-ADS (Conflicting reports)
-
15927A (MT-TT): LHON / Multiple Sclerosis / DEAF1555 increased penetrance / CHD (Reported)
-
16189C (MT-CR): Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients (Reported)
-
195C (MT-CR): BD-associated / melanoma pts (Reported)
-
8393T (MT-ATP8): Reversible brain pseudoatrophy (Reported)
|
POST_99
|
EBAGe |
Bronze Age |
Germany |
F |
-2130 |
-1930 |
K1a4a1 |
<NA>
|
176.70
|
|
Metadata
|
|
|
OBKR_82
|
EBAGe |
Bronze Age |
Germany |
F |
-2023 |
-1894 |
X2b |
reconstructed
|
184.40
|
|
FASTA
Metadata
|
|
-
12705T (MT-CO1): Possible protective factor for normal tension glaucoma (Reported)
-
13708A (MT-ND5): LHON / Increased MS risk / higher freq in PD-ADS (Conflicting reports)
-
16093C (MT-CR): Cyclic Vomiting Syndrome (Reported)
-
15927A (MT-TT): LHON / Multiple Sclerosis / DEAF1555 increased penetrance / CHD (Reported)
-
16189C (MT-CR): Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients (Reported)
-
195C (MT-CR): BD-associated / melanoma pts (Reported)
-
8393T (MT-ATP8): Reversible brain pseudoatrophy (Reported)
|
OBKR_85
|
EBAGe |
Bronze Age |
Germany |
F |
-2113 |
-1915 |
H27 |
reconstructed
|
520.20
|
|
FASTA
Metadata
|
|
-
16093C (MT-CR): Cyclic Vomiting Syndrome (Reported)
-
16129A (MT-CR): Cyclic Vomiting Syndrome with Migraine (Reported)
|
POST_111
|
EBAGe |
Bronze Age |
Germany |
F |
-2122 |
-1941 |
U5b2b2 |
reconstructed
|
29.40
|
|
FASTA
Metadata
|
|
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
12634G (MT-ND5): Thyroid Cancer Cell Line (Reported)
-
13637G (MT-ND5): Possible LHON factor (Reported)
-
150T (MT-CR): Longevity / Cervical Carcinoma / HPV infection risk (Conflicting reports)
-
16270T (MT-CR): Melanoma patients (Reported)
|
WEHR_1414
|
EBAGe |
Bronze Age |
Germany |
U |
-2022 |
-1897 |
K1a1b1g |
reconstructed
|
390.80
|
|
FASTA
Metadata
|
|
-
10398G (MT-ND3): PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy (Reported / lineage L & M marker / also hg IJK)
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
15924G (MT-TT): LIMM (Reported)
-
9055A (MT-ATP6): PD protective factor (Reported)
|
WEHR_1586
|
EBAGe |
Bronze Age |
Germany |
F |
-1951 |
-1779 |
V |
reconstructed
|
57.80
|
|
FASTA
Metadata
|
|
|
POST_131
|
EBAGe |
Bronze Age |
Germany |
F |
-2120 |
-1938 |
T2c1d+152 |
reconstructed
|
162.10
|
|
FASTA
Metadata
|
|
-
11251G (MT-ND4): Reduced risk of PD (Reported)
-
146C (MT-CR): Absence of Endometriosis (Reported)
-
15928A (MT-TT): Multiple Sclerosis / idiopathic repeat miscarriage / AD protection (Reported)
-
4216C (MT-ND1): LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage (Conflicting reports)
-
4917G (MT-ND2): LHON / Insulin Resistance / AMD / NRTI-PN (Reported)
-
6261A (MT-CO1): Prostate Cancer / LHON (Reported)
|
POST_140
|
EBAGe |
Bronze Age |
Germany |
M |
-2114 |
-1926 |
H41a |
reconstructed
|
21.00
|
|
FASTA
Metadata
|
|
-
5460A (MT-ND2): AD / PD / LHON (Conflicting reports)
|
UNTA58-62_68Sk1
|
BBC |
Bronze Age |
Germany |
M |
-2470 |
-1776 |
J1c |
reconstructed
|
691.00
|
|
FASTA
Metadata
|
|
|
UNTA58-62_68Sk2
|
BBC |
Bronze Age |
Germany |
F |
-2470 |
-2310 |
K1a |
reconstructed
|
641.40
|
|
FASTA
Metadata
|
|
|
UNTA58-62_146
|
EBAGe |
Bronze Age |
Germany |
U |
-2009 |
-1881 |
H1c |
reconstructed
|
852.20
|
|
FASTA
Metadata
|
|
|
UNTA58-62_147
|
EBAGe |
Bronze Age |
Germany |
F |
-2031 |
-1900 |
H2a1 |
reconstructed
|
372.40
|
|
FASTA
Metadata
|
|
|
UNTA58-62_149
|
EBAGe |
Bronze Age |
Germany |
U |
-2023 |
-1892 |
K1a1b1g |
reconstructed
|
767.10
|
|
FASTA
Metadata
|
|
|
UNTA58-62_150
|
EBAGe |
Bronze Age |
Germany |
U |
-2009 |
-1780 |
U5b1c2 |
reconstructed
|
1225.10
|
|
FASTA
Metadata
|
|
|
UNTA58-62_151
|
EBAGe |
Bronze Age |
Germany |
U |
-1946 |
-1886 |
U5b1c2 |
reconstructed
|
64.20
|
|
FASTA
Metadata
|
|
|
UNTA58-62_152
|
EBAGe |
Bronze Age |
Germany |
U |
-2007 |
-1779 |
U5b1c2 |
reconstructed
|
774.50
|
|
FASTA
Metadata
|
|
|
UNTA58-62_153
|
EBAGe |
Bronze Age |
Germany |
M |
-1971 |
-1776 |
R1a1a |
reconstructed
|
267.60
|
|
FASTA
Metadata
|
|
|
UNTA85_110
|
BBC |
Bronze Age |
Germany |
F |
-2290 |
-2141 |
J1c1b1a |
reconstructed
|
15.40
|
|
FASTA
Metadata
|
|
-
11251G (MT-ND4): Reduced risk of PD (Reported)
-
10398G (MT-ND3): PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy (Reported / lineage L & M marker / also hg IJK)
-
13708A (MT-ND5): LHON / Increased MS risk / higher freq in PD-ADS (Conflicting reports)
-
185A (MT-CR): Low VO2max response (Reported)
-
295T (MT-CR): Low VO2max response (Reported)
-
3010A (MT-RNR2): Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor (Reported)
-
228A (MT-CR): Low VO2max response (Reported)
-
3394C (MT-ND1): LHON / Diabetes / CPTdeficiency / high altitude adaptation (Reported / Population-dependent)
-
4216C (MT-ND1): LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage (Conflicting reports)
-
462T (MT-CR): Low VO2max response (Reported)
-
489C (MT-CR): Low VO2max response (Reported)
|
UNTA85_1343
|
BBC |
Bronze Age |
Germany |
M |
-2397 |
-2149 |
J1c2 |
reconstructed
|
417.00
|
|
FASTA
Metadata
|
|
-
11251G (MT-ND4): Reduced risk of PD (Reported)
-
10398G (MT-ND3): PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy (Reported / lineage L & M marker / also hg IJK)
-
13708A (MT-ND5): LHON / Increased MS risk / higher freq in PD-ADS (Conflicting reports)
-
185A (MT-CR): Low VO2max response (Reported)
-
295T (MT-CR): Low VO2max response (Reported)
-
3010A (MT-RNR2): Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor (Reported)
-
228A (MT-CR): Low VO2max response (Reported)
-
4216C (MT-ND1): LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage (Conflicting reports)
-
462T (MT-CR): Low VO2max response (Reported)
-
489C (MT-CR): Low VO2max response (Reported)
|
UNTA85_1163
|
EBAGe |
Bronze Age |
Germany |
M |
-2021 |
-1885 |
H23 |
reconstructed
|
192.30
|
|
FASTA
Metadata
|
|
-
1555G (MT-RNR1): DEAF / autism spectrum intellectual disability / possibly antiatherosclerotic (Cfrm)
|
OBKR_2
|
EBAGe |
Bronze Age |
Germany |
F |
-2023 |
-1894 |
K1a4a1 |
reconstructed
|
855.00
|
|
FASTA
Metadata
|
|
-
10398G (MT-ND3): PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy (Reported / lineage L & M marker / also hg IJK)
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
9055A (MT-ATP6): PD protective factor (Reported)
|
OBKR_5
|
EBAGe |
Bronze Age |
Germany |
U |
-2113 |
-1917 |
V7 |
reconstructed
|
34.20
|
|
FASTA
Metadata
|
|
-
15924G (MT-TT): LIMM (Reported)
-
7444A (MT-CO1): LHON / SNHL / DEAF (Reported)
|
OBKR_6
|
EBAGe |
Bronze Age |
Germany |
F |
-2029 |
-1903 |
V7 |
reconstructed
|
854.80
|
|
FASTA
Metadata
|
|
-
15924G (MT-TT): LIMM (Reported)
-
7444A (MT-CO1): LHON / SNHL / DEAF (Reported)
|
OBKR_9A
|
EBAGe |
Bronze Age |
Germany |
F |
-2022 |
-1892 |
K1a2a |
reconstructed
|
1004.40
|
|
FASTA
Metadata
|
|
-
10398G (MT-ND3): PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy (Reported / lineage L & M marker / also hg IJK)
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
9055A (MT-ATP6): PD protective factor (Reported)
|
OBKR_26
|
EBAGe |
Bronze Age |
Germany |
F |
-2033 |
-1907 |
HV |
reconstructed
|
391.40
|
|
FASTA
Metadata
|
|
-
16129A (MT-CR): Cyclic Vomiting Syndrome with Migraine (Reported)
|
OBKR_66
|
EBAGe |
Bronze Age |
Germany |
F |
-2028 |
-1903 |
U4a |
reconstructed
|
319.40
|
|
FASTA
Metadata
|
|
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
15693C (MT-CYB): Possibly LVNC cardiomyopathy-associated (Reported)
-
195C (MT-CR): BD-associated / melanoma pts (Reported)
-
499A (MT-CR): Endometriosis (Reported)
|
OBKR_67
|
EBAGe |
Bronze Age |
Germany |
M |
-2023 |
-1894 |
K2a5 |
reconstructed
|
147.20
|
|
FASTA
Metadata
|
|
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
146C (MT-CR): Absence of Endometriosis (Reported)
-
9055A (MT-ATP6): PD protective factor (Reported)
|
OBKR_73
|
EBAGe |
Bronze Age |
Germany |
F |
-2024 |
-1897 |
U5b2a1a1 |
reconstructed
|
3834.40
|
|
FASTA
Metadata
|
|
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
13637G (MT-ND5): Possible LHON factor (Reported)
-
150T (MT-CR): Longevity / Cervical Carcinoma / HPV infection risk (Conflicting reports)
-
16192T (MT-CR): Melanoma patients (Reported)
|
OBKR_76
|
EBAGe |
Bronze Age |
Germany |
F |
-2013 |
-1785 |
K1a |
reconstructed
|
253.90
|
|
FASTA
Metadata
|
|
-
10398G (MT-ND3): PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy (Reported / lineage L & M marker / also hg IJK)
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
16093C (MT-CR): Cyclic Vomiting Syndrome (Reported)
-
195C (MT-CR): BD-associated / melanoma pts (Reported)
-
9055A (MT-ATP6): PD protective factor (Reported)
|
OBKR_79
|
EBAGe |
Bronze Age |
Germany |
U |
-2018 |
-1883 |
H1ba |
reconstructed
|
107.40
|
|
FASTA
Metadata
|
|
-
16270T (MT-CR): Melanoma patients (Reported)
-
3010A (MT-RNR2): Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor (Reported)
|
OBKR_80
|
EBAGe |
Bronze Age |
Germany |
M |
-2134 |
-1959 |
K1a3 |
reconstructed
|
627.20
|
|
FASTA
Metadata
|
|
-
10398G (MT-ND3): PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy (Reported / lineage L & M marker / also hg IJK)
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
13708A (MT-ND5): LHON / Increased MS risk / higher freq in PD-ADS (Conflicting reports)
-
9055A (MT-ATP6): PD protective factor (Reported)
|
OBKR_81
|
EBAGe |
Bronze Age |
Germany |
F |
-2024 |
-1896 |
X2b |
reconstructed
|
715.20
|
|
FASTA
Metadata
|
|
-
12705T (MT-CO1): Possible protective factor for normal tension glaucoma (Reported)
-
13708A (MT-ND5): LHON / Increased MS risk / higher freq in PD-ADS (Conflicting reports)
-
16093C (MT-CR): Cyclic Vomiting Syndrome (Reported)
-
15927A (MT-TT): LHON / Multiple Sclerosis / DEAF1555 increased penetrance / CHD (Reported)
-
16189C (MT-CR): Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients (Reported)
-
195C (MT-CR): BD-associated / melanoma pts (Reported)
-
8393T (MT-ATP8): Reversible brain pseudoatrophy (Reported)
|
OBKR_84
|
EBAGe |
Bronze Age |
Germany |
F |
-2021 |
-1830 |
V7 |
reconstructed
|
663.10
|
|
FASTA
Metadata
|
|
-
15924G (MT-TT): LIMM (Reported)
-
7444A (MT-CO1): LHON / SNHL / DEAF (Reported)
|
OBKR_86
|
EBAGe |
Bronze Age |
Germany |
M |
-2032 |
-1901 |
K1a3 |
reconstructed
|
210.60
|
|
FASTA
Metadata
|
|
-
10398G (MT-ND3): PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy (Reported / lineage L & M marker / also hg IJK)
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
13708A (MT-ND5): LHON / Increased MS risk / higher freq in PD-ADS (Conflicting reports)
-
9055A (MT-ATP6): PD protective factor (Reported)
|
OBKR_93
|
EBAGe |
Bronze Age |
Germany |
F |
-2111 |
-1907 |
K1a4a1 |
reconstructed
|
2029.00
|
|
FASTA
Metadata
|
|
-
10398G (MT-ND3): PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy (Reported / lineage L & M marker / also hg IJK)
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
9055A (MT-ATP6): PD protective factor (Reported)
|
OBKR_95
|
EBAGe |
Bronze Age |
Germany |
F |
-2027 |
-1901 |
V1a |
reconstructed
|
461.40
|
|
FASTA
Metadata
|
|
-
16390A (MT-CR): POAG - potential for association (Reported)
|
OBKR_96
|
EBAGe |
Bronze Age |
Germany |
F |
-2013 |
-1784 |
H1j2 |
reconstructed
|
113.10
|
|
FASTA
Metadata
|
|
-
13708A (MT-ND5): LHON / Increased MS risk / higher freq in PD-ADS (Conflicting reports)
-
3010A (MT-RNR2): Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor (Reported)
|
OBKR_117
|
EBAGe |
Bronze Age |
Germany |
M |
-2019 |
-1883 |
U4a1b |
reconstructed
|
1731.20
|
|
FASTA
Metadata
|
|
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
15693C (MT-CYB): Possibly LVNC cardiomyopathy-associated (Reported)
-
195C (MT-CR): BD-associated / melanoma pts (Reported)
-
499A (MT-CR): Endometriosis (Reported)
-
745G (MT-RNR1): DEAF-associated (Reported)
|
WEHR_1192SkA
|
BBC |
Bronze Age |
Germany |
M |
-2331 |
-2150 |
K1a4a1 |
reconstructed
|
1611.30
|
|
FASTA
Metadata
|
|
-
10398G (MT-ND3): PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy (Reported / lineage L & M marker / also hg IJK)
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
9055A (MT-ATP6): PD protective factor (Reported)
|
WEHR_1192SkB
|
EBAGe |
Bronze Age |
Germany |
F |
-1918 |
-1772 |
U5b2a2b |
reconstructed
|
3962.80
|
|
FASTA
Metadata
|
|
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
13637G (MT-ND5): Possible LHON factor (Reported)
-
150T (MT-CR): Longevity / Cervical Carcinoma / HPV infection risk (Conflicting reports)
-
16189C (MT-CR): Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients (Reported)
-
16192T (MT-CR): Melanoma patients (Reported)
-
16270T (MT-CR): Melanoma patients (Reported)
|
WEHR_1193
|
EBAGe |
Bronze Age |
Germany |
F |
-1945 |
-1777 |
H4a1a1a |
reconstructed
|
936.00
|
|
FASTA
Metadata
|
|
-
10044G (MT-TG): SIDS (Unclear)
-
14582G (MT-ND6): LHON synergistic combo 14258A + 14582G (Reported: individually neutral variants causing LHON in combination)
|
WEHR_1375
|
EBAGe |
Bronze Age |
Germany |
U |
-1953 |
-1781 |
K1a3 |
reconstructed
|
29.10
|
|
FASTA
Metadata
|
|
-
10398G (MT-ND3): PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy (Reported / lineage L & M marker / also hg IJK)
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
16093C (MT-CR): Cyclic Vomiting Syndrome (Reported)
-
3316A (MT-ND1): Diabetes / LHON / PEO (Unclear)
-
9055A (MT-ATP6): PD protective factor (Reported)
|
WEHR_1380
|
EBAGe |
Bronze Age |
Germany |
M |
-2021 |
-1895 |
K1a1b1g |
reconstructed
|
160.70
|
|
FASTA
Metadata
|
|
-
10398G (MT-ND3): PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy (Reported / lineage L & M marker / also hg IJK)
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
15924G (MT-TT): LIMM (Reported)
-
9055A (MT-ATP6): PD protective factor (Reported)
|
WEHR_1415adult
|
EBAGe |
Bronze Age |
Germany |
F |
-2008 |
-1883 |
H13a2b2a |
reconstructed
|
559.50
|
|
FASTA
Metadata
|
|
|
WEHR_1415child
|
EBAGe |
Bronze Age |
Germany |
M |
-2021 |
-1893 |
H13a2b2a |
reconstructed
|
2022.20
|
|
FASTA
Metadata
|
|
|
WEHR_1474
|
EBAGe |
Bronze Age |
Germany |
M |
-2029 |
-1916 |
V |
reconstructed
|
1314.30
|
|
FASTA
Metadata
|
|
|
WEHR_1564
|
EBAGe |
Bronze Age |
Germany |
M |
-2020 |
-1892 |
V |
reconstructed
|
2467.10
|
|
FASTA
Metadata
|
|
|
Ampack_1
|
BBC |
Bronze Age |
Germany |
M |
-2476 |
-2310 |
T2b33 |
reconstructed
|
1897.40
|
|
FASTA
Metadata
|
|
-
11251G (MT-ND4): Reduced risk of PD (Reported)
-
15928A (MT-TT): Multiple Sclerosis / idiopathic repeat miscarriage / AD protection (Reported)
-
4216C (MT-ND1): LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage (Conflicting reports)
-
4917G (MT-ND2): LHON / Insulin Resistance / AMD / NRTI-PN (Reported)
|